Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can AI help family doctors spot anxiety and depression before the visit?

NCT ID NCT07834684

Diagnosis Sponsor: Singula Health, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 22, 2026 · Last updated Sep 23, 2026 · Updated 1 time

Summary

Researchers are testing an AI-powered clinical decision support system for primary care. Adult patients complete a self-report assessment before a routine visit, and the system turns their answers into a short Companion Brief for the treating clinician. A principal investigator reviews each brief before it reaches the doctor. The study measures whether the system can reliably produce and deliver these briefs, whether clinicians find them useful, and whether patients can complete the pre-visit survey.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
an AI-powered clinical decision support system that generates a clinician-facing Companion Brief
What this could lead to
If it works, primary care doctors could get a quick, structured summary of a patient's anxiety and depression symptoms before a visit, which may help them start the right conversation sooner.
What could go wrong
This is a small, single-arm pilot with 100 patients and no comparison group, so it cannot prove the briefs improve diagnosis or outcomes. The system may produce briefs that clinicians find unhelpful, or patients may not complete the pre-visit survey.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults aged 18 years or older presenting for a routine, non-urgent primary care visit at a participating independent primary care practice. Eligible patients complete a pre-visit electronic informed consent and self-report assessment (Survey 0.1) on a personal device prior to their scheduled visit.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult, aged 18 years or older at the time of consent. * Scheduled for a routine, non-urgent primary care visit at a participating practice. * Able to read and understand English at a level sufficient to complete the electronic informed consent and Survey 0.1 independently. * Has personal-device access to complete the survey (smartphone, tablet, or computer with internet). * Capable of providing informed consent. Exclusion Criteria: * Non-English-speaking, defined as inability to read English at a level sufficient to complete electronic informed consent and the survey independently. * Visually impaired to a degree that prevents independent reading of an electronic consent form on a personal device, without specialized assistive technology beyond standard mobile-device accessibility features. * Unable to read for any reason (literacy, cognitive impairment, or other). * Presenting with an acute psychiatric emergency or in acute crisis at the time of the scheduled visit, as identified by clinic staff during routine check-in. * Patient is a known minor at the time of scheduling (under 18 years). * Patient or clinician declines participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety Depression - major depressive disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Morris Medical Office

    COMPLETED

    Brentwood, New York, 11717, United States

  • WestDocs Concierge

    RECRUITING

    Mount Kisco, New York, 10549, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.